¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"platelet activating factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
platelet-activating factor
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dilution factor
Èñ¼®ÀÎÀÚ
exclusion of confounding factor
±³¶õ¹èÁ¦ÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇÇÀ¯·¡¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇÇÀ¯·¡ÀÌ¿ÏÀÎÀÚ
endurance factor
°ßµõÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
fermentation factor
¹ßÈ¿ÀÎÀÚ
fertility factor
¼öÅÂÀÎÀÚ
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷¼ºÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇǼ¼Æ÷¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷ÀÌ¿ÏÀÎÀÚ
endurance factor
Áö¼ÓÀÎÀÚ
eosinophil chemotactic factor
È£»ê±¸ÈÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸ÈÇнò¸²ÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
factor theory
¿äÀÎÀÌ·Ð
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
platelet,aggregation
ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
platelet-specific antigens
Ç÷¼ÒÆÇƯÀÌÇ׿ø
platelet-type
Ç÷¼ÒÆÇÇü(û¡)
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
platelet function disorders
Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
platelet glycoprotein
Ç÷¼ÒÆÇ´ç´Ü¹é
platelet immunologic refractory state
Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
platelet plug
platelet receptor
Ç÷¼ÒÆÇ¼ö¿ëü
platelet refractioriness
Ç÷¼ÒÆÇ¼öÇ÷ºÒÀÀÈ
platelet rich plasma
Ç÷¼ÒÆÇdzºÎÇ÷Àå
platelet satellitism
Ç÷¼ÒÆÇÀ§¼ºÇö»ó
platelet sequestration
Ç÷¼ÒÆÇ°Ý¸®(̰×î)
platelet survival measurement
Ç÷¼ÒÆÇ»ýÁ¸´ÉÃøÁ¤
platelet transfusion
Ç÷¼ÒÆÇ¼öÇ÷
platelet transfusion
Ç÷¼ÒÆÇ¼öÇ÷(¡âÃúì).
platelet,adhesion
À¯Âø(ë¨ó·),ºÎÂø(ݾó·),Á¢Âø(ïÈó·)
platelet,aggregation
ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
platelet-specific antigens
Ç÷¼ÒÆÇƯÀÌÇ׿ø
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½